MICRO-TAG
Live / Registered — Registered (as of 19 Aug 2025)
What this means for you
Registered since 19 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98746046
- Registration number
- 7898097
- Mark type
- Stylized text
- Filed
- 11 Sept 2024
- Published for opposition
- 03 Jun 2025
- Registered
- 19 Aug 2025
- Attorney of record
- Jianmin Zhou
Goods and services
- Class 001 — Chemicals: Reagents forming a fluorescence-emitting enzyme complementation system for research use; reagents for real-time cellular target engagement assay systems for research use; reagents for therapeutics discovery assays systems using DNA-encoded libraries for research use; chemical preparations for use in science other than for medical or veterinary use; biochemicals for in vitro and in vivo for scientific use; biological tissue cultures other than for medical or veterinary purposes; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents for scientific use; reagents for scientific purposes; chemical substances, namely, chemicals for scientific laboratory use; testing reagents for scientific use; universal reagents for automated test systems for scientific or laboratory research use; universal reagents for automated test systems for scientific use; chemical substances, namely, chemicals for scientific use; enzymes for scientific purposes; enzymes, other than for medical use, used in detecting proteins for scientific use; proteins in raw material form for use in science; protein in raw material form for scientific and medical research.
- Class 042 — Scientific and technological services: Research and development services in the field of cellular target engagement, discovery and testing of therapeutics; pharmaceutical drug discovery and development services; research and development in the field of therapeutics discovery; research and development in the field of challenging therapeutic targets; research and development of therapeutics for the treatment of various diseases including cancer; technical research in the field of therapeutics; technology research in the field of challenging therapeutic targets; conducting early evaluations in the field of new therapeutics; pharmaceutical products development of new therapeutic molecules belong to the class of small molecules, molecular glues, degraders, peptides and antibodies; pharmaceutical products development of new therapeutic molecules aimed at inhibiting, degrading or modifying disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders.
Owner
- NERD BIO, LLC, San Diego, CA, US
- NERD BIO, LLC, San Diego, CA, US
- NERD BIO, LLC, San Diego, CA, US
Prosecution history
- 19 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION WRITTEN
- 21 Mar 2025 — ASSIGNED TO EXAMINER
- 20 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Sept 2024 — NEW APPLICATION ENTERED